Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial.
Saved in:
| Title: | Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial. |
|---|---|
| Authors: | Aguirre FV; J.G. Mudd Cardiac Catheterization Laboratory, St. Louis University Health Sciences Center, 3635 Vista Avenue at Grand, St. Louis, MO, 63110, USA., Topol EJ, Anderson KM, Kleiman NS, Weisman HF, FitzPatrick SE, Califf RM |
| Source: | The Journal of invasive cardiology [J Invasive Cardiol] 1996; Vol. 8 Suppl B, pp. 21B-29B. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: HMP Communications Country of Publication: United States NLM ID: 8917477 Publication Model: Print Cited Medium: Internet ISSN: 1557-2501 (Electronic) Linking ISSN: 10423931 NLM ISO Abbreviation: J Invasive Cardiol |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 10785766 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Aguirre+FV%22">Aguirre FV</searchLink>; J.G. Mudd Cardiac Catheterization Laboratory, St. Louis University Health Sciences Center, 3635 Vista Avenue at Grand, St. Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Topol+EJ%22">Topol EJ</searchLink><br /><searchLink fieldCode="AU" term="%22Anderson+KM%22">Anderson KM</searchLink><br /><searchLink fieldCode="AU" term="%22Kleiman+NS%22">Kleiman NS</searchLink><br /><searchLink fieldCode="AU" term="%22Weisman+HF%22">Weisman HF</searchLink><br /><searchLink fieldCode="AU" term="%22FitzPatrick+SE%22">FitzPatrick SE</searchLink><br /><searchLink fieldCode="AU" term="%22Califf+RM%22">Califf RM</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228917477%22">The Journal of invasive cardiology</searchLink> [J Invasive Cardiol] 1996; Vol. 8 Suppl B, pp. 21B-29B. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22HMP+Communications%22">HMP Communications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8917477 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-2501 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210423931%22">10423931 </searchLink><i>NLM ISO Abbreviation: </i>J Invasive Cardiol |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=10785766 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 21B Titles: – TitleFull: Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aguirre FV – PersonEntity: Name: NameFull: Topol EJ – PersonEntity: Name: NameFull: Anderson KM – PersonEntity: Name: NameFull: Kleiman NS – PersonEntity: Name: NameFull: Weisman HF – PersonEntity: Name: NameFull: FitzPatrick SE – PersonEntity: Name: NameFull: Califf RM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 1996 Type: published Y: 1996 Identifiers: – Type: issn-electronic Value: 1557-2501 Numbering: – Type: volume Value: 8 Suppl B Titles: – TitleFull: The Journal of invasive cardiology Type: main |
| ResultId | 1 |
